HR 1862

112th CONGRESS
1st Session

H. R. 1862

To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

May 12, 2011

Mr. BILBRAY (for himself, Ms. DEGETTE, Mr. DENT, Mr. GERLACH, Mr. HOLT, Ms. FUDGE, Mr. BUTTERFIELD, and Mr. LANGEVIN) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes.

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

SEC. 2. FINDINGS.

SEC. 3. REPORT ON ONGOING FEDERAL PROGRAMS AND ACTIVITIES REGARDING REGENERATIVE MEDICINE.

SEC. 4. ESTABLISHMENT OF REGENERATIVE MEDICINE COORDINATING COUNCIL.

SEC. 5. GRANTS FOR BASIC OR PRECLINICAL RESEARCH INTO REGENERATIVE MEDICINE.

SEC. 6. GRANTS FOR DEVELOPMENT OF DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, AND BIOMATERIALS FOR USE IN REGENERATIVE MEDICINE.

SEC. 7. SUPPORTING INNOVATION IN REGENERATIVE MEDICINE THROUGH CURES ACCELERATION NETWORK.

SEC. 8. FUNDING FOR FOOD AND DRUG ADMINISTRATION RESEARCH.

END